Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |